Conroy Kevin T 4
Research Summary
AI-generated summary
Align Technology (ALGN) Director Kevin Conroy Exercises Options, Receives RSUs
What Happened
- Kevin T. Conroy, a director of Align Technology (ALGN), had derivative units converted/exercised into 1,745 common shares on May 20, 2026 (reported at $0.00 per share) and was also granted 1,836 restricted stock units (RSUs) on the same date (grant price $0.00).
- The conversion/vesting resulted in shares delivered to Conroy; the new 1,836 RSUs are a grant that will vest in the future per the grant terms. These transactions are not open‑market buys or sells.
Key Details
- Transaction date: May 20, 2026; Form 4 filed May 22, 2026 (timely).
- Derivative conversion/exercise: 1,745 shares acquired at $0.00 (reported as code M).
- Grant: 1,836 RSUs awarded at $0.00 (reported as code A); these RSUs have future vesting conditions.
- Ownership after transaction: not specified in the provided filing details.
- Footnotes:
- F1: 100% of RSUs granted May 21, 2025 vested on May 20, 2026 and shares were delivered to Conroy (this corresponds to the delivered shares).
- F2: RSUs granted May 20, 2026 will vest on the earlier of May 20, 2027 or the next annual meeting, and shares will be delivered upon vesting assuming continued service.
Context
- This activity reflects conversion/vesting and a new RSU grant rather than an open‑market purchase or sale; no cash changed hands at the reported $0.00 per‑share amounts.
- Vesting and grant transactions are common compensation events for executives and directors and do not by themselves signal a buy/sell decision.